title: P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results.
abstract: An original MRI contrast agent, called P792, is described. P792 is a gadolinium macrocyclic compound based on a Gd-DOTA structure substituted by hydrophilic arms. The chemical structure of P792 has been optimized in order to provide (1) a high r(1) relaxivity in the clinical field for MRI: 29 mM(-1)xs(-1) at 60 MHz, (2) a high biocompatibility profile and (3) a high molecular volume: the apparent hydrodynamic volume of P792 is 125 times greater than that of Gd-DOTA. As a result of this high molecular volume, P792 presents an unusual pharmacokinetic profile, as it is a Rapid Clearance Blood Pool Agent (RCBPA) characterized by limited diffusion across the normal endothelium. The original pharmacokinetic properties of this RCBPA are expected to be well suited to MR coronary angiography, angiography, perfusion imaging (stress and rest), and permeability imaging (detection of ischemia and tumor grading). Further experimental imaging studies are ongoing to define the clinical value of this compound.
authors.affiliation: Guerbet, Chemical Research, BP 50400, 95943 Roissy CDG Cedex, France. portm@guerbet-group.com
authors.forename: M
authors.initials: M
authors.lastname: Port
authors.forename: C
authors.initials: C
authors.lastname: Corot
authors.forename: O
authors.initials: O
authors.lastname: Rousseaux
authors.forename: I
authors.initials: I
authors.lastname: Raynal
authors.forename: L
authors.initials: L
authors.lastname: Devoldere
authors.forename: J M
authors.initials: JM
authors.lastname: Idée
authors.forename: A
authors.initials: A
authors.lastname: Dencausse
authors.forename: S
authors.initials: S
authors.lastname: Le Greneur
authors.forename: C
authors.initials: C
authors.lastname: Simonot
authors.forename: D
authors.initials: D
authors.lastname: Meyer
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics*; D005682:Gadolinium; D006571:Heterocyclic Compounds / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics*; D007202:Indicators and Reagents; D007928:Lethal Dose 50; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008657:Metabolic Clearance Rate; D015394:Molecular Structure; D009942:Organometallic Compounds / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D021241:Spectrometry, Mass, Electrospray Ionization; D014018:Tissue Distribution
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D007202:Indicators and Reagents; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium; C435266:contrast agent P792